The well-characterized D374Y mutation, located in the catalytic domain, enhances PCSK9's binding affinity for the epidermal growth factor-like repeat A domain of LDLR by 10- to 25-fold, causing severe hypercholesterolemia and markedly increased risk of early CAD13,14. The gene discussed is LDLR; the disease is familial hypercholesterolemia.